Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine
L. Barabino, A. Galitzia, R. Murru, G. Caocci, M. Greco, C. Targhetta, G. Angioni, A. Vacca, E. Piras, V. Frau, O. Mulas, G. La Nasa Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. luca.barabino@hotmail.com
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
L. Barabino, A. Galitzia, R. Murru, G. Caocci, M. Greco, C. Targhetta, G. Angioni, A. Vacca, E. Piras, V. Frau, O. Mulas, G. La Nasa
Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 15
Pages: 6914-6916
DOI: 10.26355/eurrev_202308_33262